메뉴 건너뛰기
Movement Disorders
Volumn 11, Issue 2, 1996, Pages 181-184
Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
Author keywords

Antibodies; Botulinum toxin type A; Botulinum toxin type F; Dystonia; Torticollis
Indexed keywords

ANTIBODY; BOTULINUM TOXIN; BOTULINUM TOXIN A;
EID: 0029991962     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110211     Document Type: Article
Times cited : (60)
References (9)
  • 1
    • 0344086268 scopus 로고
    • Botulinum toxin therapy
    • Fahn S, Marsden CD. Oxford: Butterworth/Heinemann
    • Greene PE, Fahn SF, Brin MF, Blitzer A. Botulinum toxin therapy. In: Fahn S, Marsden CD. Movement disorders 3. Oxford: Butterworth/Heinemann, 1994:477-502.
    • (1994) Movement Disorders 3 , pp. 477-502
    • Greene, P.E.1    Fahn, S.F.2    Brin, M.F.3    Blitzer, A.4
  • 2
    • 0028345811 scopus 로고
    • Development of resistance to botulinum toxin type A in patients with torticollis treated with injections of botulinum toxin type A
    • Greene PE, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis treated with injections of botulinum toxin type A. Mov Disord 1994; 9:213-217.
    • (1994) Mov Disord , vol.9 , pp. 213-217
    • Greene, P.E.1    Fahn, S.2    Diamond, B.3
  • 3
    • 0005193183 scopus 로고
    • Botulinum toxoids
    • Lewis KH, Cassel K, eds. Cincinatti: U.S. Department of Health, Education, and Welfare, Public Health Service
    • Cardella MA. Botulinum toxoids. In: Lewis KH, Cassel K, eds. Botulism: proceedings of a symposium. Cincinatti: U.S. Department of Health, Education, and Welfare, Public Health Service, 1964:113-130.
    • (1964) Botulism: Proceedings of a Symposium , pp. 113-130
    • Cardella, M.A.1
  • 4
    • 0027520207 scopus 로고
    • Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
    • Greene PE, Fahn S. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Mov Disord 1993;8:479-483.
    • (1993) Mov Disord , vol.8 , pp. 479-483
    • Greene, P.E.1    Fahn, S.2
  • 5
    • 0023614120 scopus 로고
    • Factor VIII inhibitors: Etiology, characterization, natural history, and management
    • Lusher JM. Factor VIII inhibitors: etiology, characterization, natural history, and management. Ann NY Acad Sci 1987;509:89-102.
    • (1987) Ann NY Acad Sci , vol.509 , pp. 89-102
    • Lusher, J.M.1
  • 6
    • 0027473752 scopus 로고
    • Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A
    • Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. and the Kogenate previously untreated patient study group. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. N Engl J Med 1993;328:453-459.
    • (1993) N Engl J Med , vol.328 , pp. 453-459
    • Lusher, J.M.1    Arkin, S.2    Abildgaard, C.F.3    Schwartz, R.S.4
  • 8
    • 0026571955 scopus 로고
    • Induction of immune tolerance in patients with hemophilia A and inhibitors
    • Gruppo RA, Valdez LP, Stout RD. Induction of immune tolerance in patients with hemophilia A and inhibitors. Am J Pediatr Hematol Oncol 1992;14:82-87.
    • (1992) Am J Pediatr Hematol Oncol , vol.14 , pp. 82-87
    • Gruppo, R.A.1    Valdez, L.P.2    Stout, R.D.3
  • 9
    • 0024194826 scopus 로고
    • Systemic toxicity of botulinum toxin by intramuscular injection in the monkey
    • Scott AB, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 1988;3: 333-335.
    • (1988) Mov Disord , vol.3 , pp. 333-335
    • Scott, A.B.1    Suzuki, D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.